INS and type 2 diabetes mellitus: An earlier systematic review and meta-analysis of 4 randomized controlled trials in 350 individuals with type 2 diabetes found that OBG consumption of 2.5–3.5 g/day significantly lowered HbA1c by 0.21% and fasting plasma glucose by 0.52 mmol/L, without affecting fasting plasma insulin concentrations [93].